Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
NICE Rejects Vemurafenib for Melanoma Citing Costs | |
|
| |
The National Institute of Clinical Excellence's (Nice) decision not to recommend Vemurafenib as a treatment option for melanoma patients since it is too expensive has attracted criticism from a skin cancer patient support group.
Factor 50 has urged Nice to reconsider its decision to not recommend the drug as it could prove to be a "potentially lifesaving" drug and added that the decision was same as passing a death sentence.
Vemurafenib, manufactured by Roche, costs around Ģ1,750 per patient per week and though Roche was willing to offer an undisclosed discount for the NHS, Nice decided that it was not cost effective.
"Standard treatments that have been available since the 1970s are ineffective and to deny this drug to patients, is tantamount to passing them a death sentence. I am astonished and deeply worried that Nice has not given approval to yet another drug which will significantly alter the lives of melanoma patients", Factor 50's chief executive officer Gill Nuttall said.
Source-Medindia
| |
|
|
 Comment & Contribute
|
Related Links
Melanoma
Melanoma is the most dangerous type of skin cancer. It is a cancer that develops in melanocytes, cells which produce a skin pigment called ...
Skin Cancer
Latest information on skin cancer, skin cancer types, risk factors and causes. Aspects related to skin cancer symptoms, diagnosis, treatment and ...
Drug Related News
Common Drug for Depression Reduces Stress-related Heart Condition
Researchers at Duke Medicine have found that a drug commonly used to treat depression and anxiety may improve a stress-related heart condition in ...
New, Effective Sleeping Pill from Merck to Hit US Markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall asleep and stay asleep, say reviewers at the US Food and ...
EU Agency Says Acne Pill Benefits Outweigh Blood Clot Risk
The benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins, said Europe's ...
Reduce Ambien's Dose to Avoid Drowsy Driving
U.S. Food and Drug Administration has now given the nod for new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) with a view to ...
Statins Cut Exercise Benefits
Simvastatin a type of statin was found to hinder the positive effects of exercise for obese and overweight adults. Statins, the ...
New Drug Enhances Radiation Treatment for Brain Cancer
A novel drug may significantly help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, say scientists at ...
Medwonders Health Network
- Health News Index
|
|
- News Quick Links
 |
Melanoma
Complete Medindia Resources
|
| News Categories: |
| » | Health Care Costs can be Reduced by ER Docs |
| » | Hospital Use and Costs Not Increased by Massachusetts' Health Care Reform |
| » | Preparation on for Health Care Revamping |
| » | Federal Spending to Treat Chronic Pain Should be a Top Healthcare Priority |
| » | Obama Campaigns to Advance Health Care Program |
| More Insurance News | |
|
Ask an Expert
